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1. Introduction 
Spina bifida (SB) is one of the most prevalent congenital anomalies known as neural tube 
defects (NTD) in Yucatan, at Southeast Mexico. NTD results from failures of normal neural 
tube closure between the third and fourth week of embryonic development (Chen, 2008; 
Ramirez-Espitia et al., 2003). The majority of NTD cases can be categorized as either 
anencephaly with a lack of closure in the region of the head; or spina bifida with a lack of 
closure below the head (Au et al., 2010). SB refers to defects in the vertebral arches that 
obligatorily accompany open lesions. When the neural folds remain open, the sclerotome is 
unable to cover the neuroepithelium and skeletogenesis occurs abnormally, leaving the 
midline exposed (Greene & Copp, 2009). SB encompasses several subgroups of defects 
including the protrusion of the nervous tissue and its covering through a defect in the 
vertebrae named myelomeningocele, meningocele, and lipomeningocele. Myelomeningocele 
is by far the most common, accounting for greater than 90% of SB cases (Au et al., 2010). 
Wide variations in SB prevalence based on geography, race/ethnicity, and socioeconomic 
level suggest that genetic and environmental factors contribute to its etiology (Chen, 2008). 
Maternal folate status is critical for proper neural tube closure during embryogenesis. 
However epidemiological studies suggest that factors other than maternal deficiency of folic 
acid are involved in the etiology of SB. Numerous environmental and genetic influences 
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contribute to NTD etiology; accumulating evidence from population-based studies which 
has demonstrated that folate status is a significant determinant of NTD risk. 
Since the observation that periconceptional folic acid supplementation reduces the risk of 
having a NTD-affected pregnancy by 50–70% (Czeizel & Dudas, 1992; MRC, 1991); and the 
identification of the C677T SNP in the MTHFR gene as the first genetic risk factor of NTD 
(Whitehead et al, 1995); research has focused on genetic variation in genes encoding for the 
enzymes involved in the folate cycles and the closely-related homocysteine (Hcy) 
metabolism. Folate metabolism cross-regulates a complex network of basic biological 
pathways vital to growth, differentiation, and proliferation of cells. These processes include 
folate recycling, methionine metabolism, trans-sulfuration, synthesis of purines and 
pyrimidines, synthesis of serine/glycine, biomolecule methylation, membrane lipid 
synthesis, and drug metabolism. Neural tube formation involves intricately synchronized 
cell-cycle activities of the cells composing the neural plate and neighboring tissues. 
Abnormal activity of genes affecting the balance of the aforementioned biological activities 
can lead to failure of the neural tube to close appropriately resulting in NTDs. Completion 
of neural tube closure requires the precise coordination of cell proliferation, survival, 
differentiation, and migration events; any one of these events could feasibly be disrupted by 
impairments in folate metabolism (Beudin & Stover, 2007). 
Polymorphisms in genes controlling folate–homocysteine metabolism have been 
suggested as predisposing factors and susceptibility candidates for SB. However, in 
Yucatan, Mexico, no association between NTD and two common polymorphisms, C677T 
and A198C of the methylentetrahydrofolate reductase (MTHFR) gene was found 
(Gonzalez-Herrera et al., 2002, 2007). Mutations in the MTHFR gene can only partially 
explain the protective effect of folate against NTD. Therefore, other defects in folate 
metabolism, such as defective folate receptors and carriers, could also be causes of NTD. 
Dietary folates mainly exist as polyglutamates. As the uptake and transport of folates in 
the body occurs as monoglutamates, the dietary polyglutamated folates have to be 
deconjugated to monoglutamates before absorption. The enzyme responsible for this 
deconjugation is folylpoly-γ-glutamate carboxypeptidase, which is associated with the 
intestinal apical brush border and is encoded by the glutamate carboxypeptidase II 
(GCPII) gene. After the deconjugation process the folate monoglutamates are absorbed in 
the proximal small intestine via a mechanism that involves reduced folate carrier (van der 
Linden et al., 2006). Ingested folate is hydrolyzed into monoglutamate forms in the 
intestine by means of a specialized carrier-mediated process, with a protein named the 
reduced-folate carrier (RFC-1), which only transports the reduced form of folate, 
including the physiological substrate 5-methyltetrahydrofolate. RFC-1 is a bidirectional 
anion exchanger that mediates folate delivery into a variety of cells of different origin. A 
polymorphism, A80G substitution, in exon 2 of the RFC-1 gene has been identified; that 
leads to the replacement of a histidine, CAG by an arginine, CGG, (Whetstine et al., 2001; 
Chango et al., 2000). Mutation of RFC-1 80 AA to RFC-1 GG could impair folate transport 
from maternal blood to the fetus. So, the homozygous genotype (GG) could be a 
biologically plausible risk of NTDs. The A80G polymorphism has been demonstrated as a 
genetic risk factor for NTDs in both patients and their mothers (De Marco et al., 2003, 
Shang et al., 2008). Additional studies demonstrated that this variant may interact with 
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low folate status and MTHFR mutations to increase NTDs risk. A study in a Chinese 
population has reported an increased NTD risk in patients with the GG genotype, 
especially when their mothers did not take folic acid supplements (Pei et al., 2005). Other 
studies have failed to find an association between the RFC-1 A80G SNP and maternal 
NTD risk (Relton et al., 2004a, b); although an association between the RFC-1 GG genotype 
and low erythrocyte folate levels has demonstrated (Morin et al., 2003). RFC-1 A80G SNP 
may be a NTD risk factor, especially when maternal folate status is low, suggesting that 
sufficient folate can attenuate the effect of this polymorphism. 
The objective of this study was to analyze the association of A80G polymorphism in the 
RFC1 gene with the risk for having spina bifida affected-offspring and its interaction with 
C677T-MTHFR polymorphism in mothers and fathers from Southeast, Mexico. This design 
included only parents, supporting the hypothesis that mutation of RFC1 gene on the parents 
side, mainly mother’s might alter folate metabolism, since RFC1 carrier is of particular 
importance during embryonic development for its role in transporting folate across the 
placenta. Moreover, metabolic changes, such as limiting the supply of folate to the embryo 
or facilitating the accumulation and increased transfer of homocysteine, could foster the 
formation of NTD.  
2. Methods 
2.1 Population 
A case-control association study was performed, including as cases, 183 parents of children 
with open-dorsolumbar SB (119 mothers and 64 fathers). Case mothers and fathers were 
unrelated subjects belonging to 108 different families. The affected children were the first 
occurrence in the nuclear family and they were born consecutively between 1998 and 2004 at 
the General Hospital of the Secretary of Health of Yucatan, Mexico. Age of cases ranged 
from 15 to 57 years old and a mean age of 21.6 years. The control group was composed with 
195 unrelated volunteer healthy parents (140 mothers and 55 fathers) who have 
demonstrated having healthy offspring in at least three consecutive children, not having SB 
or other type of NTD nor delivered an NTD-affected child. The control group was formed 
with volunteers who attended to Laboratorio de Genética at Universidad Autónoma de 
Yucatán for other diseases different to congenital malformations. Control subjects had a 
mean age of 35.3 years and range of 17–60 years. Folate dietary consumption based on a 
questionnaire of frequency of foods and folate erythrocyte concentrations were previously 
measured in case and control mothers, and no significant differences were found between 
them (Duarte-Pinzón et al., 2008). All selected subjects were born and had lived for at least 
three generations in Yucatan, Mexico. We also used anthropologic and demographic 
parameters such as language, birth place, surnames, genealogy, history of lifestyle; among 
others, to mach ethnically control with case subjects, belonging to the same ethnic group of 
Mestizos, defined as individuals born in the country having a Spanish-derived last name, 
with family antecedents of Mexican ancestors back at least to the third generation. In 
addition, we previously determined the absence of substructure or population stratification 
within the population of Yucatan by using 16 autosomal STR markers (González-Herrera et 
al., 2010), which may represent a confounder. Subjects with a chronic or degenerative 
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disease, such as diabetes mellitus type 2, obesity or hypertension were not included. 
Informed consent was obtained from cases and controls according to the recommendations 
of Helsinki Declaration. This study was approved by the Bioethics Committee of Centro de 
Investigaciones Regionales, Universidad Autónoma de Yucatán, México. Confidentiality of 
participants was strictly maintained. 
2.2 Genotyping 
DNA was extracted from blood using standard techniques. Genotyping for A80G 
polymorphism in the RFC1 gene was performed by polymerase chain reaction amplification 
and restriction fragment length polymorphism (PCR-RFLP). The SNP A80G was determined 
with PCR amplification using conditions and primers described by Chango et al., 2000: 
forward: 5’-AGT GTC ACC TTC GTC CCC TC-3’ and reverse 5’- CTC CCG CGT GAA GTT 
CTT-3’. PCR amplification produced a 230 bp DNA fragment, which was digested with 
HhaI restriction enzyme. Detection of the fragments was resolved on 4% agarose gel. After 
restriction enzyme digestion, analysis of RFC-1 230 bp fragments showed that the AA 
genotype had two fragments of 162 and 68 bp, the heterozygous AG genotype had four 
fragments of 162, 125, 68, and 37 bp, and the homozygous GG genotype had three fragments 
of 125, 68, and 37 bp. To ensure quality control of genotyping, 10% of samples were 
randomly selected and genotyped by a second investigator, resulting in 100% concordance. 
Samples that failed the amplification or digestion as well as doubtful results were repeated 
to ensure correct identification of variants. 
2.3 Statistical analysis 
Genotype and allele frequencies in cases and controls were determined by counting method 
and calculating proportions. The frequencies of genotypes and alleles were used to compare 
cases and controls by means of a standard X2 analysis. Exact methods were considered 
preferable whenever expected values in any cell were < 5. The Hardy-Weinberg equilibrium 
analysis was calculated both in cases and controls, and was tested using X2 statistics for 
goodness of fit (1 df). Association of A80G-RFC1 genotypes with the risk of having a SB-
affected child was estimated considering p values <0.05 as statistically significant and odds 
ratio (OR) with 95% confidence interval (CI) were calculated using STATA case-control odds 
ratio program with the Woolf method (STATA version 10.2). Frequencies of A80G-RFC1 
genotypes and alleles were also stratified by gender, in order to determine the maternal or 
paternal contribution to the risk for having a SB-affected child. Interaction of A80G-RFC1 
polymorphism with C677T-MTHFR was assessed using data previously reported (Gonzalez-
Herrera et al., 2002). 
3. Results 
Genotype and allele frequencies for A80G polymorphism of RFC1 gene for SB parents and 
their controls, Hardy-Weinberg expectations, as well as the comparison of frequencies 
between cases and controls on an association analysis are listed in Table 1. Genotype 
frequencies were distributed according to Hardy-Weinberg expectations (p>0.05) in cases 
and controls. The heterozygous AG genotype was as frequent as the homozygous GG 
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genotype in cases, whereas heterozygous AG was the most frequent genotype in controls. 
Allele G showed a higher frequency than allele A in cases, whereas allele distribution was 
similar in controls. Comparison of A80G-RFC1 genotype frequency between parents 
having an SB-affected child and control parents did not show significant differences nor 
for the AG heterozygous genotype neither for GG genotype, except when compare the GG 
genotype versus AA+AG (p= 0.009). Distribution of frequency of allele G was also 
significantly higher in cases than controls (p= 0.04). These findings suggested that both 
allele G and GG genotype were associated with the parental risk of having an SB-affected 
child. 
 
Genotypes 
and alleles 
SB
Parents 
N= 183
Control
Parents 
N= 195
Cases vs controls
OR     (95% CI)        p 
AA 
AG 
GG 
Allele A 
Allele G 
 
HWE (p) 
30 (0.164)
77 (0.421) 
76 (0.415) 
137 (0.372) 
229 (0.628) 
 
(0.609) 
35 (0.180)
104 (0.533) 
56 (0.287) 
174 (0.446) 
216 (0.554 
 
(0.764) 
Reference
AA vs AG    0.863   (0.489 – 1.527)    0.662 
AA vs GG    1.583    (0.871 – 2.878)   0.171 
Reference 
A vs G     1.37    (1.01 – 1.801)     0.046** 
GG vs AA+AG  1.76  (1.15 – 2.703)     0.009** 
Table 1. Genotype and allele frequencies of A80G- RFC1 polymorphism in parents of SB 
children and control parents from Southeast, Mexico. Counts (%). ** Significant 
 
Genotypes 
and alleles 
SB 
Fathers
N= 64 
Control 
Fathers 
N= 55 
SB 
Mothers
N= 119 
Control 
Mothers
N= 140 
SB fathers vs control 
fathers 
OR [95% CI] p 
 
SB Mothers vs control 
mothers 
OR [95% CI] p 
AA 8 (0.125) 10 (0.182) 22 (0.185) 25 (0.179) Reference Reference 
AG 26 (0.406) 28 (0.509) 51 (0.429) 76 (0.543) 1.161 [0.397 – 3.391] 0.500 0.763 [0.389 –1.496] 0.490 
GG 30 (0.469) 17 (0.309) 46 (0.387) 39 (0.279) 2.206 [0.731 –6.652] 0.173 1.34 [0.656 – 2.738] 0.470 
     GG vs AG+AA 1.972 
[0.928 –4.191] 0.056 
GG vs AG+AA 1.631 
[0.968 – 2.751] 0.044** 
Allele A 42 (0.328) 48 (0.436) 95 (0.399) 126 (0.450) Reference Reference 
Allele G 86 (0.672) 64 (0.564) 143 (0.601) 154 (0.550) 1.536 [0.908 – 2.597] 0.070 1.232 [868 – 1.748] 0.248 
HWE (p) 0.937 0.999 0. 736 0.710   
Table 2. Genotype and allele frequencies of A80G- RFC1 polymorphism in parents of SB 
children and control parents from Southeast, Mexico stratified by gender. Counts (%). ** 
Significant. 
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Table 2 shows the genotype and allele frequencies for A80G-RFC1 gene for SB parents and 
their controls stratified by gender in order to determine the maternal or paternal 
contribution to the risk for having a SB-affected child in the studied population. The 
heterozygous AG genotype was as frequent as the GG genotype in case fathers, whereas for 
case mothers as well as for control mothers and fathers, the heterozygous AG genotype was 
the most frequent. Stratification of the polymorphism A80G-RFC1 frequency by gender did 
not show significant differences when comparing case fathers versus control fathers for any 
genotype or allele (p>0.05). Comparison of genotype and allele frequencies of 
polymorphism A80G-RFC1 between case mothers versus control mothers, showed 
significant differences for the genotype GG when comparing against AA+AG genotypes, 
suggesting that the polymorphism A80G-RFC1 is associated with the risk for having SB-
affected offspring only in mothers (OR=1.63, IC 0.968-2.75, p= 0.04). These results 
demonstrate that the risk for having an SB-affected child is controlled maternally in the 
population of Southeast, Mexico. 
 
Genotype 
combinations 
RFC1/ 
MTHFR 
SB 
Mothers
N=119 
Control 
Mothers
N=140 
SB mothers vs control 
mothers 
OR 95% CI p 
SB 
Fathers
N=64 
Control 
Fathers
N= 55 
SB Fathers vs control 
Fathers 
OR 95% CI p 
AA/CC 
AG/CC 
GG/CC 
AA/CT 
AG/CT 
GG/CT 
AA/TT 
AG/TT 
GG/TT 
4 (0.034)
12 (0.101)
8 (0.067)
12 (0.101)
25 (0.210)
25 (0.210)
6 (0.050)
14 (0.118)
13 (0.109)
4 (0.036)
18 (0.129)
9 (0.064)
13 (0.093)
44 (0.314)
17 (0.121)
7 (0.050)
14 (0.100)
13 (0.093)
1.18 [0.29 - 4.83] 0.546
0.76 [0.35 -1.65] 0.561 
1.04 [0.39 - 2.81] 0.559
1.09 [0.47 - 2.50] 0.836
0.58 [0.32 - 1.02] 0.039**
1.92 [0.98 - 3.76] 0.039**
1.00 [0.32 - 3.08] 0.603
1.27 [0.54 – 2.63] 0.691
1.19 [0.53 – 2.69] 0.683
0 (0.0) 
5 (0.078)
8 (0.125)
7 (0.109)
14 (0.219)
11 (0.172)
1 (0.016)
7 (0.109)
11 (0.172)
2 (0.036)
10 (0.182)
2 (0.036)
4 (0.073)
11 (0.200)
12 (0.218)
4 (0.073)
7 (0.127)
3 (0.055)
0.00 [0.00-0.00] 0.211 
0.38 [0.12-1.19] 0.077 
3.78 [0.76-18.64] 0.077 
1.68 [0.46-6.09] 0.534 
1.12 [0.46-2.72] 0.826 
0.74 [0.29-1.85] 0.643 
0.20 [0.02-1.86] 0.180 
0.84 [0.27-2.57] 0.783 
2.59 [0.94-13.63] 0.043** 
Table 3. Interaction of A80G-RFC1 and C677T-MTHFR polymorphisms in parents of SB 
children and control parents stratified by gender. Counts (%). ** Significant 
Combined genotypes for both polymorphisms A80G-RFC1 and C677T-MTHFR were 
determined in order to asses an interaction between these two genes since multiple SNPs 
have the potential to provide significantly more power for genetic analysis than individual 
SNPs for increasing the associated risk for having SB-affected offspring. The genotype 
combination with both heterozygous AG/CT was the most frequent in all studied groups, 
except for control fathers who showed the highest frequency for the genotype combination 
GG/CT. Comparison of genotype combination RFC1/MTHFR frequencies between SB 
parents and control parents did not show significant differences (p>0.05, data not shown). 
However, stratification by gender of RFC1/MTHFR interaction showed significant 
differences for the genotype combinations AG/CT and GG/CT in mothers (p=0.039), 
suggesting that AG/CT might be an interaction associated as a genetic protection factor and 
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that the GG/CT genotype combination might represent a genetic risk factor having an SB-
affected child for mothers. In fathers, the genotype combination with both mutants GG/TT 
was significantly associated with the risk for having SB-affected offspring (p=0.043). 
Frequencies of A80G-RFC1/C677T-MTHFR genotype combinations stratified by gender in 
the studied population, as well as the comparison of frequencies between cases and controls 
on an association analysis are listed in Table 3. Results of the interaction of A80G-
RFC1/C677T-MTHFR suggest that for a genotype combination become a genetic risk factor 
for having SB-affected offspring in Southeast, Mexico; the homozygous genotype GG-RFC1 
should be present for both mothers and fathers. 
4. Discussion 
Variants of several folate-related genes have been found to be significantly associated with 
the risk of NTD, although, many genetic factors are also responsible for NTD due to the 
numerous candidates and population level differences. Previous investigations of the gene 
that are specifically involved in folate metabolism, such as 5,10-methylenetetrahydrofolate 
reductase gene (MTHFR) have shown that MTHFR is associated with an increased risk of 
NTD (Botto & Yang, 2000). There is a considerable body of data demonstrating that MTHFR 
gene 677TT homozygosity for the thermolability of the enzyme and MTHFR A1298C are 
genetic factors affecting the susceptibility of the NTD risk. However, in Yucatan, Mexico, no 
association between NTD and two common polymorphisms, C677T and A1298C of the 
methylentetrahydrofolate reductase (MTHFR) gene was found (Gonzalez-Herrera et al., 
2002, 2007). Mutations in the MTHFR gene can only partially explain the protective effect of 
folate against NTD. In this study, we search for another genetic folate risk factor, which 
might explain the high prevalence of NTD, of SB type in Yucatan, Mexico. Therefore, other 
defects in folate metabolism, such as defective folate receptors and carriers, could also be 
causes of NTD. The carrier involved in cellular folate absorbed and transported, such as the 
reduced folate carrier (RFC), acts together with the folate receptor for folate internalization 
from tissue into the cytoplasm of the cells. Investigation of folate-related genes is necessary 
to reveal clues about metabolism underlying the potential embryonic protective effects of 
folic acid supplementation. Genes involved in the cellular folate transportation, such as 
RFC1, may be primary candidates for folate regulated NTDs (Shaw et al., 2003). Variance or 
abnormal expression of RFC1 can potentially have a major impact on folate metabolism and 
represents an excellent candidate for explaining susceptibility to folate-regulated NTDs 
(Shaw et al., 2002).  
The A80G polymorphism has been demonstrated as a genetic risk factor for NTDs in both 
patients and their mothers (De Marco et al., 2003, Shang et al., 2008). These findings are 
agreed with our results obtained in the population of Yucatan, where we were able to 
demonstrate a significant association of both allele and GG genotype of A80G-RFC1 
polymorphism with the risk for having an SB-affected child. Previous familial based-
association studies using transmission/disequilibrium test (TDT) have demonstrated the 
significant preference of the allele G to be transmitted to NTD-affected offspring in affected 
families compared with control families (Pei et al., 2005). In the population of Yucatan, the 
risk for having SB-affected offspring associated to A80G-RFC1 polymorphism was mainly 
significant in mothers. Because the affected biological mechanism related to A80G-RFC1 
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polymorphism is folate transport; additional folate supplementation is critical to maintain 
the optimal function of folate carriers and transporters, as well as folate adsorption, mainly 
in mothers. The folate transport occurs across the placenta in mothers , so maternal control 
of folate is determinant to maintain optimal folate serum and erythrocyte levels in order to 
assure an embryonic normal development. RFC-1 is a high-affinity transporter for the folate 
substrate 5-methyltetrahydrofolate. This carrier is of particular importance during 
embryonic development for its role in transporting folate across the placenta. The 80A>G 
mutation affects residue 27 of the protein in which the Arginine (or R; CGG codon) is 
changed into Histidine (or H; CAG codon). RFC-1 is a protein that requires a functional 
amino terminus for insertion into the cell membrane for folate transport. Mutation of RFC-1 
80 AA to RFC-1 GG could impair folate transport from maternal blood to the fetus. 
Therefore, this homozygous genotype (GG) could be a biologically plausible risk of NTD 
(Shang et al., 2008).  
As a maternal low folate/high homocysteine phenotype is associated with increased risk of 
NTD in offspring, women with the GG genotype may have an increased risk of having a 
child affected by an NTD relative to those with the GA and AA genotypes. In addition, 
GG homozygous women may be at increased risk of a range of other major pathologies, 
including cardiovascular disease, in which a low folate/high homocysteine phenotype is a 
predisposing feature (Stanisławska-Sachadyn, et al 2009). A previous report in California 
provided evidence for a gene-nutrient interaction between infant RFC1 G80/G80 
genotype and maternal periconceptional intake of vitamins containing folic acid on the 
risk of spina bifida (Shaw et al., 2002). Based on these studies, we hypothesized that 
infants with the RFC1 (A80G) genotype would be at increased risk for NTD secondary to 
an impaired ability to transport folates to the cytoplasm of a critical cellular population. 
The metabolic changes, such as limiting the supply of folate to the embryo or facilitating 
the accumulation and increased transfer of homocysteine, could foster the formation of 
NTD, so it is the mutation of certain genes on the mother’s side that would alter folate 
metabolism. Significant association between the RFC-1 A80G polymorphism and NTD 
risk in Shanxi, China, especially for the occurrence of the upper type of NTD was 
observed (Shang et al., 2008).  
The biologically plausible rationale for exploring genetic variation of RFC1 is based on the 
knowledge that RFC1 regulates the delivery of 5-methyltetrahydrofolate from the cell’s 
endocytotic vesicle into the cytoplasm (Chango et al., 2000). 5- Methyltetrahydrofolate is 
required for the remethylation of homocysteine. RFC is also a protein that requires a 
functional amino terminus for insertion into the cell membrane for folate transport. Thus, 
increasing maternal serum folate from either supplements or diet could ‘‘correct’’ reduced 
kinetics of transport that result from a variant form of a folate membrane transport 
protein (Shaw et al., 2003). If a putative genetic defect was severe enough to eliminate 
RFC1- mediated folate transport through these systems, it is likely that it would be 
embryolethal. This has been substantiated by recent reports using knock-out mouse 
models for the folate receptor proteins, as well as for RFC1 (Gelineau-van et al., 2008). 
Mutation of RFC1 80AA to RFC1 80GG could impair folate transport from maternal blood 
to the fetus. Therefore, this homozygous genotype (GG) could be a biologically plausible 
risk of NTD (Pei et al., 2009) 
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There is evidence of an interaction between the methylenetetrahydrofolate reductase 
(MTHFR) 1298 A>C and the reduced folate carrier (RFC1) 80 G>A polymorphisms with the 
risk of birth defects in the Italian population (De Marco et al., 2003). Gene–gene interactions 
between MTHFR and RFC1 gene polymorphisms and the risk of Down syndrome 
pregnancies in a group of young mothers showed a protective role for the MTHFR 
1298AA/RFC1 80 GA or AA genotype, compared with the 1298AA/80 GG genotype, 
suggesting that interactions between MTHFR and RFC1 gene polymorphisms could be 
relevant to the risk for Down syndrome (Coppede et al., 2006, 2007). These findings 
suggested that there is a significant interaction between maternal or offspring’s GG 
genotype and the deficiency of maternal periconceptional folic acid. Otherwise, a modest 
gene-nutrient interaction between infant homozygosity for the RFC1 GG genotype and 
maternal periconceptional intake of vitamins containing folic acid on the risk of spina bifida 
has been demonstrated: an increased risk for spina bifida among California newborns with 
the GG genotype whose mothers had not used vitamins with folic acid in the 
periconceptional period (Shaw et al., 2002). 
Our study contributed with the identification of genotypes at risk for having SB-affected 
offspring in fathers and mothers from Yucatan, Mexico. Allele G as well as GG genotype of 
A80G-RFC1 polymorphism are associated with the risk to have a child with SB, so this 
polymorphism might be recognized as a genetic marker for susceptibility to SB in the 
studied population. Results might impact the design of preventive programs in order to 
decrease the high prevalence of NTD in Yucatán, Mexico. 
5. Conclusion 
In conclusion, our findings suggest the association of allele G of A80G polymorphism in 
the RFC1 gene with the genetic risk for having a child affected of spina bifida, which 
might be controled maternally. Results also suggest that there might be an interaction 
between A80G-RFC1 and C677T-MTHFR, since the genotype combinations GG/CT in 
mothers and GG/TT in fathers were associated with the higher risk to have a child with 
SB in Southeast, Mexico.  
6. References 
Au, SK., Ashley-koch, A., & Northrup, H. (2010). Epidemiologic and genetic aspects of spina 
bifida and other neural tube defects. Developmental disabilities research reviews 
Vol.16, pp 6–15, ISSN: 1940-5529. 
Beaudin, A. & Stover, P. (2007). Folate-Mediated One-Carbon Metabolism and Neural Tube 
Defects: Balancing Genome Synthesis and Gene Expression. Birth Defects Research 
Vol.81, pp183–203, ISSN:1542-0752. 
Botto, L.D., & Yang, Q. (2000). 5,10 Methylenetetrahydrofolate reductase gene variants and 
congenital anomalies: a Huge Review. American Journal of Epidemiology Vol.151 
pp862–877, ISSN: 0002-9262. 
www.intechopen.com
 
Neural Tube Defects – Role of Folate, Prevention Strategies and Genetics 
 
188 
Chen, C.P. (2008). Syndromes, disorders and maternal risk factors associated with neural 
tube defects (VI). Taiwan Journal of Obstetrics and Gynecology Vol.47, pp267–275, 
ISSN:1028-4559. 
Chango, A., Emery-Fillon, N., de Courcy, G.P., Lambert, D., Pfister, M., Rosenblatt, D.S. & 
Nicolas, J.P. (2000) A polymorphism (80G>A) in the reduced folate carrier gene and 
its associations with folate status and homocysteinemia. Molecular Genetics and 
Metabolism Vol.70, pp310–315, ISSN: 1096-7192. 
Coppede, F., Marini, G., Bargagna, S., & Stuppia, L. (2006). Folate gene polymorphisms and 
the risk of Down syndrome pregnancies in young Italian women. American Journal 
of Medical Genetics A. Vol140, pp1083-1091, ISSN: 1552-4825. 
Coppede, F., Colognato, R., & Migliore, L. (2007). MTHFR and RFC-1 gene polymorphisms 
and the risk of Down syndrome in Italy. Author’s response to the comments by 
Scala et al. [2007]. American Journal of Medical Genetics Vol.143A, pp1018–1019, ISSN: 
1552-4825. 
Czeizel, A.E., & Dudas, I. (1992). Prevention of the first occurrence of neural-tube defects by 
periconceptional vitamin supplementation. New England Journal of Medicine Vol, 
327, pp1832–1835, ISSN: 0028-4793. 
De Marco, P., Calevo, M.G., Moroni. A, Merello, E., Raso, A., Finnell, RH., Zhu, H., 
Andreussi, L., Cama, A. & Capra, V. (2003). Reduced folate carrier polymorphism 
(80A>G) and neural tube defects. European Journal of Human Genetics Vol.11 pp245–
252, ISSN: 1018-48-13. 
Duarte-Pinzón, V., López-Ávila, MT., González-Herrera, L., & Gamas-Trujillo, PA. (2008). 
Consumo habitual de alimentos con ácido fólico en madres de niños con defectos 
de cierre del tubo neural y en mujeres con descendencia sana. In: Ramírez-Sierra, 
M.J., Jímenez-Coello, M., Heredia-Navarrete, M. R., Moguel-Rodríguez, W.A. 
Investigación y Salud 3. Las ciencias de la Salud en el marco de los procesos de 
cambio y globalización. Ediciones de la Universidad Autónoma de Yucatán. Yucatán, 
México. pp253-273, ISBN: 978-607-7573-03-6.  
Gelineau-van Waes, J., Heller, S., Bauer, LK., Wilberding, J., Maddox, JR., Aleman, F., 
Rosenquist, TH., Finnell, RH. (2008). Embryonic development in the reduced folate 
carrier knockout mouse is modulated by maternal folate supplementation. Birth 
Defects Reseach Vol.82, pp494-507, ISSN: 1542-0752. 
González-Herrera, L., García-Escalante, G., Castillo-Zapata, I., Canto-Herrera, J., Ceballos-
Quintal, J., Pinto-Escalante, D., Díaz-Rubio, F., Del Angel, RM., & Orozco-Orozco, 
L. (2002). Frequency of the thermolabile variant C677T in the MTHFR gene and lack 
of association with neural tube defects in the State of Yucatan, Mexico. Clinical 
Genetics Vol.62, pp394-398, ISSN: 0009-9163. 
González-Herrera, L., Castillo-Zapata, I., Garcia-Escalante, G., & Pinto-Escalante, D. 
(2007). A1298C polymorphism of the MTHFR gene and neural tube defects in the 
State of Yucatan, Mexico. Birth Defects Research Vol.79, pp622-626, ISSN:1542-
0752. 
González-Herrera, L., Vega-Navarrete, L., Roche-Canto, C., Canto-Herrera, J., Virgen-Ponce, 
D., Moscoso-Caloca, G., Delgado-Nájar, E., Quintanilla-Vega, B., Cerda-Flores, RM. 
(2010). Forensic parameters and genetic variation of 15 autosomal STR Loci in 
www.intechopen.com
Association of A80G Polymorphism in the RFC1 Gene with the Risk for  
Having Spina Bifida-Affected Offspring in Southeast Mexico and Interaction with C677T-MTHFR 
 
189 
Mexican Mestizo populations from the States of Yucatan and Nayarit. The Open 
Forensic Science Journal Vol.3, pp57-63, ISSN: 1874-40-28. 
Greene, N., & Copp, A. (2009). Development of the vertebrate central nervous system: 
formation of the neural tube. Pregnatal Diagnosis Vol.29, pp303–311, ISNN: 1097-
0223. 
Morin, I., Devlin, AM., Leclerc, D., Sabbaghian, N., Halsted, CH., Finnell, R. & Rozen, R. 
(2003). Evaluation of genetic variants in the reduced folate carrier and in glutamate 
carboxypeptidase II for spina bifida risk. Molecular Genetics and Metabolism Vol.79, 
pp197–200, ISSN: 1096-7192. 
MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: results of the 
Medical Research Council Vitamin Study. Lancet Vol.338, pp131–137, ISSN: 0140-
6736. 
Pei, L., Zhu, H., Ren, A., Li, Z., Hao, L., Finnell, RH. & Li, Z. (2005) Reduced folate carrier 
gene is a risk factor for neural tube defects in a Chinese population. Birth Defects 
Research Vol.73A, pp430–433, ISSN:1542-0752.. 
Pei, L., Liu, J., Zhang, Y., Zhu, H., & Ren, A. (2009). Association of Reduced Folate Carrier 
Gene Polymorphism and Maternal Folic Acid Use With Neural Tube Defects. 
American Journal of Medical Genetics Vol.150B, pp874–878, ISSN: 1552-4825. 
Ramirez-Espitia, J., Benavides, F., Lacasaña-Navarro, M., Martinez, J., García, A., & Benach, 
J. (2003). Mortality from neural tube defects in Mexico, 1980–1997. Salud Publica de 
Mexico Vol.45, pp356–364, ISNN: 0036-3634. 
Relton, CL., Wilding, CS., Laffling, AJ., Jonas, PA., Burgess, T., Binks, K., Janet, TE. & Burn J. 
(2004a). Low erythrocyte folate status and polymorphic variation in folate-related 
genes are associated with risk of neural tube defect pregnancy. Molecular Genetics 
and Metabolism Vol.81, pp273–281, ISSN: 1096-7192.  
Relton, CL., Wilding, CS., Pearce, MS., Laffling, AJ., Jonas, PA., Lynch, SA., Tawn, EJ. & 
Burn, J. (2004b). Gene-gene interaction in folate-related genes and risk of neural 
tube defects in a UK population. Journal of Medical Genetics Vol.41, pp256–260, ISSN: 
1468-6244. 
Shang, Y., Zhao, H., Niu, B., Li, W., Zhou, R., Zhang, T.,& Xie, J. (2008). Correlation of 
Polymorphism of MTHFR and RFC-1 Genes with Neural Tube Defects in China. 
Birth Defects Research Vol.82, pp3–7, ISSN: 1542-0752. 
Shaw, GM., Lammer, EJ., Zhu, H., et al. (2002). Maternal periconceptional vitamin use, 
genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. 
American Journal of Medical Genetics Vol.108, pp1–6, ISSN: 1552-4825. 
Shaw, G., Zhu, H., Lammer, E., Yang, W., & Finnell, R. (2003). Genetic Variation of Infant 
Reduced Folate Carrier (A80G) and Risk of Orofacial and Conotruncal Heart 
Defects. American Journal of Epidemiology Vol.158, pp747–752, ISSN: 0002-9262. 
Stanisławska-Sachadyn, A., Mitchell, L., Woodside, J., Buckley, P., Kealey, C., Young, I., 
Scott, J., Murray, L., Boreham, C., McNulty, H., Strain, J., & Whitehead, A.(2009). 
The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with 
red cell folate concentrations among women. Annals of Human Genetics Vol.73, 
pp:484-491, ISSN: 1469-1809. 
www.intechopen.com
 
Neural Tube Defects – Role of Folate, Prevention Strategies and Genetics 
 
190 
van der Linden, I., Afman, L., Heil, S., & Blom, H. (2006). Genetic variation in genes of folate 
metabolism and neural-tube defect risk. Proceedings of the Nutrition Society Vol.65, 
pp204–21, ISSN: 0029-6651. 
Whetstine, J., Gifford, A., Witt, T., Liu, X., Flatley, R., Norris, M., Haber, M., Taub, J., 
Ravindranath, Y., & Matherly, L (2001). Single Nucleotide Polymorphisms in the 
Human Reduced Folate Carrier: Characterization of a High-Frequency G/A 
Variant at Position 80 and Transport Properties of the His27 and Arg27 Carriers. 
Clinical Cancer Research Vol. 7, pp3416–3422, ISSN: 1078-0432. 
www.intechopen.com
Neural Tube Defects - Role of Folate, Prevention Strategies and
Genetics
Edited by Dr. Kannan Laksmi Narasimhan
ISBN 978-953-51-0317-2
Hard cover, 200 pages
Publisher InTech
Published online 16, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The book Neural Tube Defects - Role of Folate, Prevention Strategies and Genetics has several eminent
international authors and the book is a resource for anybody who is interested in this very important subject.
The authors are distinguished and the chapters are a product of their extensive research.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Lizbeth González-Herrera, Orlando Vargas-Sierra, Silvina Contreras-Capetillo, Gerardo Pérez-Mendoza,
Ileana Castillo-Zapata, Doris Pinto-Escalante, Thelma Canto de Cetina and Betzabet Quintanilla-Vega (2012).
Association of A80G Polymorphism in the RFC1 Gene with the Risk for Having Spina Bifida-Affected Offspring
in Southeast Mexico and Interaction with C677T-MTHFR, Neural Tube Defects - Role of Folate, Prevention
Strategies and Genetics, Dr. Kannan Laksmi Narasimhan (Ed.), ISBN: 978-953-51-0317-2, InTech, Available
from: http://www.intechopen.com/books/neural-tube-defects-role-of-folate-prevention-strategies-and-
genetics/association-of-a80g-polymorphism-in-the-rfc1-gene-with-the-risk-for-having-spina-bifida-affected-off
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
